Latest1 information on COVID-19
©2022 Stanford Medicine
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
Not Recruiting
Trial ID: NCT01203436
Purpose
The purpose of this trial was to determine the efficacy and safety of supplemental
therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce
the probability of progression to threshold ROP and the need for peripheral retinal ablation.
Official Title
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
- Infants with prethreshold retinopathy of prematurity, confirmed by 2 certified
ophthalmologic exams
- Median pulse oxygen saturation <94% in room air
- Median pulse oxygen saturation can be kept safely >96% on oxygen/ventilator
Exclusion Criteria:
- No fatal congenital anomaly or congenital eye anomaly
Intervention(s):
procedure: Supplemental Oxygen Management
procedure: Conventional Oxygen Management
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305